Andersson B S, Sadeghi T, Siciliano M J, Legerski R, Murray D
Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer Chemother Pharmacol. 1996;38(5):406-16. doi: 10.1007/s002800050504.
The objective of this study was to determine the relative importance of the first six complementation groups of the nucleotide excision repair cross-complementing genes (ERCC1-ERCC6) and the first complementation group of the X-ray repair cross-complementing genes (XRCC1), in the repair of DNA damage induced by the in vitro active cyclophosphamide (CP) derivatives 4-hydroperoxycyclophosphamide (4HC) and phosphorodiamidic mustard (PM). We compared the sensitivity of the wild-type CHO cell line, AA8, with that of the CHO mutant cell lines UV4 and UV20 (ERCC1-), UV5 (ERCC2-), UV24 (ERCC3-), UV41 (ERCC4-), UV135 (ERCC5-), UV61 (ERCC6-), and EM9 (XRCC1-). Cell survival was determined using both growth inhibition and conventional clonogenic assays. The yield of DNA crosslinks in selected cell lines was determined using an ethidium bromide fluorescence assay.
The rank ordering of sensitivity to both 4HC and PM, based on the combined survival data, was UV41/UV4/UV20 > > UV61/UV24/UV135/EM9 > or = UV5 approximately AA8. Thus mutations in the ERCC1 and ERCC4 genes impart a hypersensitivity to CP analogs. To confirm the importance of the ERCC1 gene for cellular resistance to 4HC and PM, UV20 cells were transfected with the human ERCC1 gene and subsequently exposed to 4HC and PM. The transfected cells displayed essentially wild-type resistance to both drugs. Furthermore, two interspecific hybrids derived from UV41, both of which retained the region of human chromosome 16 that harbors the ERCC4 gene, displayed essentially wild-type resistance to 4HC and PM, confirming the importance of ERCC4 for the repair of 4HC-induced DNA damage. When crosslinks were assayed after a 60-min treatment with 4HC or a 15-min treatment with PM, their yield paralleled the sensitivity of the cell lines to both drugs: UV41 cells showed markedly elevated levels of crosslinks, whereas AA8 and UV5 cells showed similar (low) levels of crosslinks.
Our findings confirm the general pattern indicating that the ERCC1 and ERCC4 gene products are crucial for the repair of 4HC-induced DNA damage, while the other nucleotide excision repair genes examined are relatively unimportant. These data suggest that the hypersensitivity of ERCC1- and ERCC4- mutants to DNA crosslinking agents may reflect a defect in recombinational repair rather than nucleotide excision repair.
本研究的目的是确定核苷酸切除修复交叉互补基因(ERCC1 - ERCC6)的前六个互补组以及X射线修复交叉互补基因(XRCC1)的第一个互补组在体外活性环磷酰胺(CP)衍生物4 - 氢过氧环磷酰胺(4HC)和磷酰胺芥(PM)诱导的DNA损伤修复中的相对重要性。我们比较了野生型CHO细胞系AA8与CHO突变细胞系UV4和UV20(ERCC1 - )、UV5(ERCC2 - )、UV24(ERCC3 - )、UV41(ERCC4 - )、UV135(ERCC5 - )、UV61(ERCC6 - )和EM9(XRCC1 - )的敏感性。使用生长抑制和传统的克隆形成试验来确定细胞存活率。使用溴化乙锭荧光测定法测定选定细胞系中DNA交联的产量。
根据综合存活数据,对4HC和PM的敏感性排序为UV41/UV4/UV20 >> UV61/UV24/UV135/EM9 ≥ UV5 ≈ AA8。因此,ERCC1和ERCC4基因中的突变使细胞对CP类似物敏感。为了证实ERCC1基因对细胞抵抗4HC和PM的重要性,用人类ERCC1基因转染UV20细胞,随后将其暴露于4HC和PM。转染后的细胞对两种药物均表现出基本的野生型抗性。此外,来自UV41的两个种间杂种,都保留了含有ERCC4基因的人类16号染色体区域,对4HC和PM表现出基本的野生型抗性,证实了ERCC4对4HC诱导的DNA损伤修复的重要性。在用4HC处理60分钟或用PM处理15分钟后检测交联时,其产量与细胞系对两种药物的敏感性平行:UV41细胞显示出明显升高的交联水平,而AA8和UV5细胞显示出相似(低)的交联水平。
我们的研究结果证实了一般模式,表明ERCC1和ERCC4基因产物对于4HC诱导的DNA损伤修复至关重要,而所检测的其他核苷酸切除修复基因相对不重要。这些数据表明,ERCC1和ERCC4突变体对DNA交联剂的敏感性可能反映了重组修复而非核苷酸切除修复的缺陷。